The PneumoLiner, a tissue container bag to be used in morcellator procedures, has been approved by the U.S. Food and Drug Administration (FDA). The device is comprised of a containment bag and tube-like plunger that delivers the device to the abdominal cavity. Removed tissue will be placed in the bag and sealed to prevent the spread of cancerous cells.
About 1 in 350 estimated women that undergo a hysterectomy or myomectomy due to fibroids may have undetected uterine cancer. The FDA still warns against the dangers of morcellators, but is allowing the use of the PneumoLiner when the uterine tissue is not suspected to be cancerous, only for women without uterine fibroids being treated with a hysterectomy, and for some pre-menopausal women with fibroids who are still hoping to have children.
William Maisel, M.D., M.P.H., deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health (CDRH), said in a statement, “We want to be clear that, although the device has been shown to successfully contain morcellated tissue, it has not been proven to reduce the risk of cancer spread during surgery.”
If you have faced complications from a morcellator treatment and are looking for legal options, contact the attorneys of Williams Kherkher at (800) 220-9341.
As of March 15, 2016, there are about 31 pending morcellator lawsuits filed by women who had hysterectomies or uterine fibroid removal against J&J’s Ethicon unit before Judge Kathryn H. Vratil in Kansas, according to the Judicial Panel on Multidistrict Litigation.
In 2014, the U.S. Food and Drug Administration released a warning that about 1 in 350 women had an undiagnosed uterine cancer that could be spread by the surgical device. Lawsuits against Johnson & Johnson (J&J) and Ethicon claim the devices are defective and that the company knew about the possibility of spreading cancer but failed to warn the public. J&J claimed that their morcellators have always included cautions in their instruction for use about the potential spread of malignant tissue. J&J is already in talks to settle more of its cases. Individual settlements differ based on the specific injuries and circumstances of the case, but so far, the range of each settlement runs from $100,000 to about $1 million, according to Wall Street Journal.
If you have suffered from the aggressive growth of cancer after undergoing a medical procedure that made use of a power morcellator, please speak with our lawyers at Williams Kherkher. Call us today at (800) 220-9341 to learn more about your rights.
Risperdal or Risperidone (generic) is a medication that works in the brain to treat schizophrenia. It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic. Risperidone works to balance dopamine and serotonin to adjust behavior.
Risperidone may help some or all of the following symptoms of schizophrenia:
- Hallucinations – imagined voices or images that seem real
- Delusions – beliefs that are not true (e.g., other people are reading your thoughts)
- Disorganized thinking or trouble organizing your thoughts and making sense
- Little desire to be around other people
- Trouble speaking clearly
- Lack of motivation
Risperidone is also FDA approved for the following indications:
- Acute treatment of manic or mixed episodes of bipolar disorder
- Maintenance (long-term) treatment of bipolar disorder (Risperdal Consta only)
- Irritability associated with autistic disorders
If you are planning on becoming pregnant, notify your healthcare provider to best manage your medications. Untreated schizophrenia has risks to the fetus, as well as the mother.
If you were treated with Risperdal for reasons other than those the drug is meant to treat and faced adverse side effects, you may be eligible for compensation. Call the attorneys at Williams Kherkher to speak with a representative. Our phone number is (800) 220-9341.
A morcellator is a device used to trap cancerous tissue during hysterectomies and surgeries to remove fibroids. The devices resemble a drill with sharp blades at the end. Doctors insert the long, tube-like portion into small incisions in the abdomen, perform morcellation of the uterus or fibroid by chopping up the tissue, and vacuum it out of the body.
The use of morcellators has been linked to cancer growth in women. The U.S. Food and Drug Administration allowed an Irish company to market its new power morcellator tissue collection system. The bag promises to trap potentially cancerous tissue and prevent it from spreading in the body, but the new tool is not guaranteed to stop the spread of cancer.
If you have suffered from the aggressive growth of cancer after undergoing a medical procedure involving a power morcellator, please speak with the lawyers at Williams Kherkher. Call us today at (800) 220-9341 to learn more about your rights and to hold negligent parties responsible.
Risperdal, or risperidone, is an antipsychotic drug used to treat schizophrenia, some symptoms of bipolar disorder, and irritability in children with autism.
Risperidone is not approved for use when an individual has dementia because it may increase the risk of death in older adults. Doctor’s advice is also needed before giving the drug to a child. When taking Risperdal, individuals should drink plenty of fluids as it can cause overheating and dehydration. Risperdal may impair your thinking or reactions. Mild side effects are headache, fever, stiff muscles, confusion, sweating, fast or uneven heartbeats, tremors, trouble swallowing, dry mouth, dizziness, or fainting. Other adverse effects may include gynecomastia (male breast tissue enhancement), diabetes, sexual dysfunction, heart attacks, suicidal thoughts, pancreatitis, and bone loss.
If you or a loved one has experienced side effects or complications after using Risperdal, you may be eligible to file a claim against the manufacturer. Contact the Risperdal attorneys of Williams Kherkher today at (800) 220-9341 to learn how we can help you.
When male individuals experience hormonal imbalances such that their estrogen level increases relative to their androgen hormone, their breasts may become unusually large. Though some cases of gynecomastia improve during puberty after several months, other men with this condition may consider the following treatments if the problem persists.
Patients may want to lessen breast volume by undergoing selective estrogen receptor modulator (SERM) therapy
Patients may be advised to take medications like Danazol or Clomiphene
Older patients, or those who have abnormal hormone levels, may be advised to undergo testosterone replacement
Individuals who have serious cases of gynecomastia are usually required to undergo mammoplasty surgery to reduce their breast size
Although men who develop gynecomastia only have a small chance of contracting breast cancer, they are likely to suffer from psychological problems from having unusually large breasts.
Gynecomastia, unfortunately, is one of the dangerous side effects of taking Risperdal for the treatment of conditions such as schizophrenia, autism, and bipolar disorder. If you think that taking Risperdal has caused your gynecomastia, the talented legal team at Williams Kherkher may be able to represent you. Call our offices at (800) 220-9341 to learn more about your legal options and discuss your situation.
A woman who has been diagnosed with uterine cancer is often required to undergo a surgical procedure, depending on how advanced the cancer is and how feasible it is to prevent cancer from spreading to other parts of the body.
A gynecologic surgeon may perform a hysterectomy to remove the cervix and the uterus of the patient if the tumor found is likely to spread to other parts of the body. In a “radical hysterectomy,” the surgeon may also need to remove some parts of the vagina. Vaginal parts like the ovaries and fallopian tubes may also be removed if the patient is menopausal. In some instances, a surgeon may want to find out whether the cancer spread to the patient’s lymph nodes by performing a “sentinel lymph node biopsy.” The procedures are then followed by strategic therapy sessions to fully suppress cancer cells.
Unfortunately, uterine cancer treatment is often expensive, leaving patients and their families struggling with great financial loss. However, if your cancer has spread as the result of a morcellation surgery, the legal team at Williams Kherkher may be able to work for you. Find out how we may help you get the compensation you deserve by calling (800) 220-9341.
The earliest symptom indicating that a woman may have uterine cancer is when a lump or tumor starts to develop in the uterus as a result of uncontrollable growth or change of cells in the uterine cavity. Women who are considering undergoing diagnostic tests should note the possible symptoms of this kind of reproductive cancer:
- Painful urination or other problems urinating
- Abnormal bleeding in the vagina that can come in the form of discharge or spotting
- Any pain felt around the pelvic region
- Pain during sexual intercourse
- Abnormal bleeding in the uterus or menorrhagia
Uterine cancer in the female’s reproductive system may also spread to other parts of the body. Women are advised to immediately see their physician if they experience any of these symptoms.
Unfortunately, some women who undergo a myomectomy or hysterectomy may experience the spread of uterine cancer as a result of using power morcellators during the procedure. If undergoing a morcellator surgery has caused the spread of your cancer, the lawyers at Williams Kherkher may be able to help you. Call our office at (800) 220-9341 to find out how we could help you receive the compensation you need for recovery.
Yesterday, attorney Steven Kherkher of Williams Kherkher won a $46.5 million verdict against Monsanto and three other companies in a 10-2 jury decision in a St. Louis Circuit Court. Kherkher represented 3 plaintiffs in this case – which is just the latest in a string of lawsuits against Monsanto – alleging that Monsanto was aware of a connection between polychlorinated biphenyls (PCBs) exposure and non-Hodgkin lymphoma, but that they continued to market the compounds as safe for use into the 1970s.
The jury award included $17.5 million for the three named plaintiffs in the case, as well as another $29 million in punitive damages against Monsanto and the three other defendants. When asked about the jury’s decision, a 24-year-old juror in the case stated “I think it goes to show that large companies can put stuff out there that’s harmful and they can do it for along [sic] time but that justice is going to be served whether it’s a year after the products are put out, or in this case, 80 years.”
From 1935 to 1977, Monsanto was the leading manufacturer of PCBs in the United States, which were used widely in paint, food packaging materials, and industrial equipment, among other products. The EPA banned the use of PCBs in 1979, stating that “PCBs have caused birth defects and cancer in laboratory animals, and they are a suspected cause of cancer and adverse skin and liver effects in humans.”
At Williams Kherkher, we are proud to announce that John Boundas, a partner here at the firm, has been selected to Super Lawyers once again; John has earned the recognition each and every year since 2009. He was also named a Super Lawyers Rising Star in both 2004 and 2009.
In order to be selected to Super Lawyers, attorneys must pass through a four step selection process in which they are nominated by peers, evaluated through independent research, evaluated by their peers, and then finally selected for recognition. Only 5% of lawyers are actually selected to Super Lawyers. That being said, our entire team would like to congratulate John on his fine work and for once again earning this recognition.
1 2 3 … 38 Next »